BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang WC, Deng B, Seffouh A, Ortega J, Long CA, Suresh RV, He X, Miura K, Lee SM, Wu Y, Lovell JF. Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment. NPJ Vaccines 2020;5:23. [PMID: 32218995 DOI: 10.1038/s41541-020-0173-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang W, Chiem K, Martinez-sobrido L, Lovell JF. Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2. Pathogens 2022;11:1035. [DOI: 10.3390/pathogens11091035] [Reference Citation Analysis]
2 McLeod B, Mabrouk MT, Miura K, Ravichandran R, Kephart S, Hailemariam S, Pham TP, Semesi A, Kucharska I, Kundu P, Huang WC, Johnson M, Blackstone A, Pettie D, Murphy M, Kraft JC, Leaf EM, Jiao Y, van de Vegte-Bolmer M, van Gemert GJ, Ramjith J, King CR, MacGill RS, Wu Y, Lee KK, Jore MM, King NP, Lovell JF, Julien JP. Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses. Immunity 2022:S1074-7613(22)00350-8. [PMID: 35977542 DOI: 10.1016/j.immuni.2022.07.015] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Huang WC, Mabrouk MT, Zhou L, Baba M, Tachibana M, Torii M, Takashima E, Locke E, Plieskatt J, King CR, Coelho CH, Duffy PE, Long C, Tsuboi T, Miura K, Wu Y, Ishino T, Lovell JF. Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages. Commun Biol 2022;5:773. [PMID: 35915227 DOI: 10.1038/s42003-022-03688-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Campora S, Ghersi G. Recent developments and applications of smart nanoparticles in biomedicine. Nanotechnology Reviews 2022;11:2595-631. [DOI: 10.1515/ntrev-2022-0148] [Reference Citation Analysis]
5 Lyons FMT, Gabriela M, Tham W, Dietrich MH. Plasmodium 6-Cysteine Proteins: Functional Diversity, Transmission-Blocking Antibodies and Structural Scaffolds. Front Cell Infect Microbiol 2022;12:945924. [DOI: 10.3389/fcimb.2022.945924] [Reference Citation Analysis]
6 Azlyna ASN, Ahmad S, Husna SMN, Sarmiento ME, Acosta A, Norazmi MN, Mohamud R, Kadir R. Review: Liposomes in the prophylaxis and treatment of infectious diseases. Life Sci 2022;:120734. [PMID: 35760094 DOI: 10.1016/j.lfs.2022.120734] [Reference Citation Analysis]
7 Gutiérrez Rodelo C, Salinas RA, Armenta Jaimearmenta E, Armenta S, Galdámez-martínez A, Castillo-blum SE, Astudillo-de la Vega H, Nirmala Grace A, Aguilar-salinas CA, Gutiérrez Rodelo J, Christie G, Alsanie WF, Santana G, Thakur VK, Dutt A. Zinc associated nanomaterials and their intervention in emerging respiratory viruses: Journey to the field of biomedicine and biomaterials. Coordination Chemistry Reviews 2022;457:214402. [DOI: 10.1016/j.ccr.2021.214402] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
8 Tretiakova DS, Vodovozova EL. Liposomes as Adjuvants and Vaccine Delivery Systems. Biochem (Mosc) Suppl Ser A Membr Cell Biol 2022;16:1-20. [PMID: 35194485 DOI: 10.1134/S1990747822020076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yu S, Wang J, Luo X, Zheng H, Wang L, Yang X, Wang Y. Transmission-Blocking Strategies Against Malaria Parasites During Their Mosquito Stages. Front Cell Infect Microbiol 2022;12:820650. [DOI: 10.3389/fcimb.2022.820650] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Scaria PV, Anderson C, Muratova O, Alani N, Trinh HV, Nadakal ST, Zaidi I, Lambert L, Beck Z, Barnafo EK, Rausch KM, Rowe C, Chen B, Matyas GR, Rao M, Alving CR, Narum DL, Duffy PE. Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques. NPJ Vaccines 2021;6:148. [PMID: 34887448 DOI: 10.1038/s41541-021-00407-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 He X, Zhou S, Dolan M, Shi Y, Wang J, Quinn B, Jahagirdar D, Huang WC, Tsuji M, Pili R, Ito F, Ortega J, Abrams SI, Ebos JML, Lovell JF. Immunization with short peptide particles reveals a functional CD8+ T-cell neoepitope in a murine renal carcinoma model. J Immunother Cancer 2021;9:e003101. [PMID: 34862254 DOI: 10.1136/jitc-2021-003101] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 He X, Zhou S, Quinn B, Huang WC, Jahagirdar D, Vega M, Ortega J, Long MD, Ito F, Abrams SI, Lovell JF. Position-Scanning Peptide Libraries as Particle Immunogens for Improving CD8+ T-Cell Responses. Adv Sci (Weinh) 2021;8:e2103023. [PMID: 34716694 DOI: 10.1002/advs.202103023] [Reference Citation Analysis]
13 Hills RA, Howarth M. Virus-like particles against infectious disease and cancer: guidance for the nano-architect. Curr Opin Biotechnol 2021;73:346-54. [PMID: 34735984 DOI: 10.1016/j.copbio.2021.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 He X, Zhou S, Huang WC, Seffouh A, Mabrouk MT, Morgan MT, Ortega J, Abrams SI, Lovell JF. A Potent Cancer Vaccine Adjuvant System for Particleization of Short, Synthetic CD8+ T Cell Epitopes. ACS Nano 2021;15:4357-71. [PMID: 33606514 DOI: 10.1021/acsnano.0c07680] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 19.0] [Reference Citation Analysis]
15 Federizon J, Feugmo CGT, Huang WC, He X, Miura K, Razi A, Ortega J, Karttunen M, Lovell JF. Experimental and Computational Observations of Immunogenic Cobalt Porphyrin Lipid Bilayers: Nanodomain-Enhanced Antigen Association. Pharmaceutics 2021;13:98. [PMID: 33466686 DOI: 10.3390/pharmaceutics13010098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
16 Huang WC, Zhou S, He X, Chiem K, Mabrouk MT, Nissly RH, Bird IM, Strauss M, Sambhara S, Ortega J, Wohlfert EA, Martinez-Sobrido L, Kuchipudi SV, Davidson BA, Lovell JF. SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination. Adv Mater 2020;32:e2005637. [PMID: 33111375 DOI: 10.1002/adma.202005637] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 18.5] [Reference Citation Analysis]
17 Kaslow DC. Malaria vaccine research & innovation: the intersection of IA2030 and zero malaria. NPJ Vaccines 2020;5:109. [PMID: 33298967 DOI: 10.1038/s41541-020-00259-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Lovell JF. Thinking outside the macrocycle: Potential biomedical roles for nanostructured porphyrins and phthalocyanines — a SPP/JPP Young Investigator Award paper. J Porphyrins Phthalocyanines 2020;24:1272-7. [DOI: 10.1142/s1088424620300086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Huang WC, Deng B, Mabrouk MT, Seffouh A, Ortega J, Long C, Miura K, Wu Y, Lovell JF. Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose. Malar J 2020;19:309. [PMID: 32859199 DOI: 10.1186/s12936-020-03368-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
20 Scaria PV, Chen BB, Rowe CG, Alani N, Muratova OV, Barnafo EK, Lambert LE, Zaidi IU, Lees A, Rausch KM, Narum DL, Duffy PE. Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230. Vaccine 2020;38:5480-9. [PMID: 32600913 DOI: 10.1016/j.vaccine.2020.06.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]